Four ways to successfully guide and reshape clinical trials to meet the needs of our ever changing social, economic and regulatory climate.
How to get the most of out of your UAT process and focus your efforts where they should be.
Six things that high-performing clinical research sites do that make sponsors return to them again and again.
Increasingly central in the course of drug development is the inclusion of observational studies, including registries, which provide insights missing from traditional interventional studies.
This white paper discusses the role of the pharmacy in a modern day Phase I clinical research unit and its role in understanding the safety and pharmacology of a drug before Phase II can begin.
How the right team and tools can make all the difference in clinical trial rescue scenarios.
Successfully sourcing commercial products for comparative studies often proves far more challenging than assumed.
Clinical trial sponsors face many challenges in clinical trials – including how to mitigate risks that could cause delays and increase trial costs.
In this webinar, INC Research/inVentiv Health experts discuss the factors that sponsors must take into account as they design and execute clinical trials in this space, beginning with a review of the immunotherapy landscape.
The webinar focuses issues and bottlenecks that contribute to delays that are outside of the CRA control.
This webinar covers the study assessing sponsor and CRO experience, practices and improvement areas associated with investigative site identification, feasibility, selection and study startup.
To be successful, your molecule deserves unparalleled experience in Alzheimer’s Disease clinical research. You need a research partner with an uncommon understanding of the complexities associated with evaluating patients with various phenotypes and the ability to implement specific design features to mitigate the risks and challenges specific to Alzheimer’s studies.
The right sites can make all the difference. At WCG, we help clients to identify, select, and engage the highest performing investigators for their clinical research trials.
The WIRB-Copernicus Group® (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research- reviewing over 3,000 new protocols and over 15,000 new PIs annually- more than all of our competitors combined.